CombiMatrix to Present at September Investment Conferences
September 08, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Sept. 08, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Notes Decision by Health Care Service Corporation to Reimburse for Recurrent Pregnancy Loss Testing
August 16, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Aug. 16, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Announces Distribution Agreement with Universal Diagnostic Laboratories for Miscarriage Analysis Testing
August 10, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE and VAN NUYS, Calif., Aug. 10, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health...
CombiMatrix Corporation Reports Second Quarter 2016 Financial and Operating Results
August 03, 2016 16:05 ET
|
CombiMatrix Corporation
Revenue growth, gross margin expansion and strong cash reimbursement support progress toward goal of profitability Conference Call Begins Today at 4:30 p.m. Eastern Time IRVINE, Calif., Aug. 03,...
CombiMatrix Corporation to Release 2016 Second Quarter Financial Results on August 3, 2016
July 27, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., July 27, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three and six months ended June 30, 2016 after...
CombiMatrix Study Published in Genetics in Medicine Establishes the Superior Diagnostic Value of Microarray Analysis over Karyotyping for Recurrent Pregnancy Loss Testing
June 24, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., June 24, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing...
CombiMatrix to Present at Upcoming Investment Conferences
May 25, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre-implantation genetic...
CombiMatrix Corporation Reports First Quarter 2016 Financial and Operating Results
May 04, 2016 16:05 ET
|
CombiMatrix Corporation
Revenues Increase 28% to $3.0 Million on Record Reproductive Health Genetic Screening Test Volume and Higher Average Revenue per Test Conference Call Begins Today at 4:30 p.m. Eastern Time ...
CombiMatrix Corporation to Release 2016 First Quarter Financial Results on May 4, 2016
April 27, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three months ended March 31, 2016 after market close...
CombiMatrix Provides Strategic Update
April 21, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., April 21, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...